CliffBio
small molecule

CLOLAR

CLOFARABINE

Loss of exclusivity—loss of exclusivity
CompanyGenzyme →See this company's full patent-cliff portfolio

Drug detail

Brand nameCLOLAR
Active ingredientCLOFARABINE
Strength20MG/20ML (1MG/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalDecember 2004
Marketing statusDISCN

More from Genzyme

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.